Next step in drug delivery: Getting to individual organelles

Drug Delivery and Translational Research

Volumn 2, Issue 6, 2012, Pages 415-417

  Torchilin, Vladimir P ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRIMER; DRUG CARRIER; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; NANOCARRIER; PACLITAXEL; POLYMER;

ACETYLATION; ANTISENSE THERAPY; BIOACCUMULATION; BIODEGRADATION; CELL MEMBRANE; CELL NUCLEUS; CELL ORGANELLE; CONFOCAL MICROSCOPY; CONJUGATION; CYTOPLASM; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; EDITORIAL; ENDOCYTOSIS; ENDOSOME; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE THERAPY; HELA CELL; HUMAN; LIPOSOMAL DELIVERY; LYSOSOME; MITOCHONDRION; MULTIDRUG RESISTANCE; OBESITY; PH; PRIORITY JOURNAL;

EID: 84869055492     PISSN: 2190393X     EISSN: 21903948     Source Type: Journal    
DOI: 10.1007/s13346-012-0102-2     Document Type: Editorial

References (14)

1. Torchilin VP. Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu Rev Biomed Eng. 2006; 8: 343-75.
2. Hymel D, Peterson BR. Synthetic cell surface receptors for delivery of therapeutics and probes. Adv Drug Deliv Rev. 2012; 64(9): 797-810. doi: 10. 1016/j. addr. 2012. 02. 007.
3. Karanth H, Murth RS. pH-sensitive liposomes-principle and application in cancer therapy. J Pharm Pharmacol. 2007; 59(4): 469-83.
4. Koren E, Torchilin VP. Cell-penetrating peptides: breaking through to the other side. Trends Mol Med. 2012; 18(7): 385-93. doi: 10. 1016/j. molmed. 2012. 04. 012.
5. Raj B. Nanoparticle-based therapeutics in humans: a survey. Nanotechnol Law Bus. 2008; 5(2): 135-55.
6. El-Sayed A, Masuda T, Akita H, Harashima H. Stearylated INF7 peptide enhances endosomal escape and gene expression of PEGylated nanoparticles both in vitro and in vivo. J Pharm Sci. 2012; 101(2): 879-82. doi: 10. 1002/jps. 22807.
7. Lachmann RH. Enzyme replacement therapy for lysosomal storage diseases. Curr Opin Pediatr. 2011; 23(6): 588-93. doi: 10. 1097/MOP. 0b013e32834c20d9.
8. Serviddio G, Romano AD, Cassano T, Bellanti F, Altomare E, Vendemiale G. Principles and therapeutic relevance for targeting mitochondria in aging and neurodegenerative diseases. Curr Pharm Des. 2011; 17(20): 2036-55.
9. Gogvadze V. Targeting mitochondria in fighting cancer. Curr Pharm Des. 2011; 17(36): 4034-46.
10. Meerovich I, Koshkaryev A, Thekkedath R, Torchilin VP. Screening and optimization of ligand conjugates for lysosomal targeting. Bioconjug Chem. 2011; 22(11): 2271-82. doi: 10. 1021/bc200336j.
11. Koshkaryev A, Thekkedath R, Pagano C, Meerovich I, Torchilin VP. Targeting of lysosomes by liposomes modified with octadecyl-rhodamine B. J Drug Target. 2011; 19(8): 606-14. doi: 10. 3109/1061186X. 2010. 550921.
12. Biswas S, Dodwadkar NS, Sawant RR, Koshkaryev A, Torchilin VP. Surface modification of liposomes with rhodamine-123-conjugated polymer results in enhanced mitochondrial targeting. J Drug Target. 2011; 19(7): 552-61. doi: 10. 3109/1061186X. 2010. 536983.
13. Biswas S, Dodwadkar NS, Piroyan A, Torchilin VP. Surface conjugation of triphenylphosphonium to target poly(amidoamine) dendrimers to mitochondria. Biomaterials. 2012; 33(18): 4773-82. doi: 10. 1016/j. biomaterials. 2012. 03. 032.
14. Chernenko T, Sawant RR, Miljkovic M, Quintero L, Diem M, Torchilin V. Raman microscopy for noninvasive imaging of pharmaceutical nanocarriers: intracellular distribution of cationic liposomes of different composition. Mol Pharm. 2012; 9(4): 930-6. doi: 10. 1021/mp200519y.